Medicina
Estudios Clínicos Adell
Low-Dose Orlistat Effects on Body Weight of Mildly to Moderately Overweight Individuals: A 16 Week, Double-Blind, Placebo- Controlled Trial
James W Anderson, Susan M Schwartz, Jonathan Hauptman, Mark Boldrin, Maureen Rossi, Vidhu Bansal, and Cecilia A Hale
The Annals of Pharmacotherapy n 2006 October, Volume 40
Orlistat for the management of overweight individuals and obesity: a review of potential for the 60-mg, over-the-counter dosage
James W Anderson
Expert Opin. Pharmacother. (2007) 8(11):1733-1742
Orlistat in the Long-term Treatment of Obesity in Primary Care Settings
Jonathan Hauptman, MD; Charles Lucas, MD; Mark N. Boldrin, MS; Harry Collins, MD
Arch Fam Med. 2000;9:160-167
Orlistat in the prevention of diabetes in the obese patient
Marcio C Manzini, Alfredo Halpern
Vascular Health and Risk Management 2008:4(2) 325–336